baber/WOPTO huggingface dataset:
Patent CA-2723916-A1 (CA)
Inventor: SCHUEMANN UWE
IPC: C08G18/12
Filed: 2009-05-12
Abstract: The invention relates to hydroxyl-functionalised polyurethane hot melt prepolymers comprising the chemical reaction product of isocyanate-reactive starting materials with at least one isocyanate-containing starting material. Said prepolymers are characterised in that the isocyanate-reactive starting materials of the hydroxyl-functionalised polyurethane hot melt prepoly-mers have a polypropylene glycol with a functionality higher than two and a number-average molar mass higher than or equal to 3,000 g/mol, a polypropylene glycol with a functionality less than or equal to two and a number-average molar mass less than or equal to 1,000 g/mol, and a chain lengthener with a functionality less than or equal to 500 g/mol, and the isocyanate-containing starting material of the hydroxyl-functionalised polyurethane hot melt prepolymer has an aliphatic or alicyclic diisocyanate.
Patent CA-2724047-A1 (CA)
Title: Barcoded lottery ticket, system and method for producing and validating the same
Inventor: YOUNG ERIC ANDREW
IPC: G06V30/224
Filed: 2010-12-06
Abstract: A system and method of providing and validating a bar-code on a lottery ticket to allow secure verification of tickets is described. Lottery ticket information comprising unique identifying information uniquely identifying the lottery ticket and validation information for use in determining a prize value associated with the lottery ticket is generated. First redundancy information is generated using the validation information and a portion of the unique identifying information. The first redundancy information used for checking the integrity of subsequently received validation information. The validation information is encrypted and second redundancy information is generated using the unique identifying information and the encrypted validation information. A first bar-code is constructed using the unique identifying information, the encrypted validation information and the second redundancy information. The first bar-code is printed on the lottery ticket and at least a part of the first bar-code is covered with scratch-off material.
Patent CA-2728336-A1 (CA)
Inventor: LANE MICHAEL T
IPC: B29C49/02
Filed: 2009-06-24
Abstract: A one-piece plastic container includes a body that defines a longitudinal axis and has an upper portion, a sidewall portion, and a base portion. The upper portion defines an opening into the container. The sidewall portion is integrally formed with and extends from the upper portion to the base portion. The base portion closes off an end of the container. The one-piece plastic container is formed from resin having an intrinsic viscosity (IV) of about 0.73 or less.
Patent CA-2728495-A1 (CA)
Inventor: KENT GAGE A
IPC: A01K1/015
Filed: 1998-11-25
Abstract: A grain-based animal litter is disclosed. In accordance with the invention, the animal litter comprises discrete plural particles of a grain-based substrate, which particles tend to agglomerate into clumps when wetted. The litter of the invention absorbs liquids such as animal excretions, and substantially reduces the odor thereof. Preferably, the substrate is a grain germ; more preferably, the substrate is a corn germ; most preferably, the substrate is washed, spent grain germ. In accordance with a preferred embodiment of the invention, the grain germ is provided in the form of discrete plural granules, each of which granules includes a cohesiveness agent in an amount sufficient to enhance the cohesiveness of the granule.
Patent CA-2728808-A1 (CA)
Inventor: MAIN MARK JONATHAN
IPC: A61K9/14
Filed: 2009-02-02
Abstract: The present invention relates to pharmaceutical compositions comprising triptans, such as sumatriptan, and their uses in therapy. In particular, the invention relates to compositions for administration via the inhaled route.
Patent CA-2731353-A1 (CA)
Inventor: DAFTARY GAUTAM VINOD
IPC: A61K9/107
Filed: 2009-07-22
Abstract: The present invention describes Stable injectable oil-in-water Docetaxel nanoemulsion composition having Doc-etaxel concentrations as high as 20 mg/ml, devoid of hypersensitivity reaction and fluid retention,. It employs Synthetic triglyc-erides, and DSPE PEG-2000, Natural phosphatides, Polyhydric alcohol and Water for injection. In another embodiment lyophilised products with added Cryoprotectants have been described which on reconstitution gives nanoemulsion suitable for parenteral administration.
Patent CA-2733419-A1 (CA)
Title: Nouveau procede de pronostic associe aux cas d'hemorragies post-partum
Inventor: MEBAZAA ALEXANDRE
IPC: A61B5/02
Filed: 2009-08-06
Abstract: La présente invention concerne un procédé in vitro de pronostic d'un arrêt du saignement chez une patiente atteinte d'hémorragie post-partum en l'absence de procédure invasive, comprenant les étapes suivantes : (a) déterminer, à partir d'un échantillon biologique de ladite patiente, la concentration plasmatique de fibrinogène, la concentration sanguine de troponine ainsi que le temps de prothrombine; (b) étudier au moins deux marqueurs cliniques de ladite patiente choisis dans le groupe constitué de la fréquence cardiaque et de la présence d'anomalies de placentation; (c) calculer un score Z selon la formule suivante : Z= a+ b + c+ d + e; où a est associé à l'existence d'anomalies de placentation chez ladite patiente, avec a valant 0 lorsque aucune anomalie de placentation n'est observée chez ladite patiente et a valant 1 lorsqu'une ou plus anomalies de placentation sont observées chez ladite patiente; où b est associé à la fréquence cardiaque de ladite patiente avec b valant 0 lorsque la fréquence cardiaque de ladite patiente est inférieure ou égale à 115 bpm (battements par minute) et b valant 1 lorsque la fréquence cardiaque est supérieure à 115 bpm; où c est associé à la concentration plasmatique de fibrinogène de ladite patiente avec c valant 0 lorsque ladite concentration est supérieure ou égale à 2 g/L et c valant 1 lorsque ladite concentration est inférieure à 2g/L; où d est associé à la concentration sanguine en troponine de ladite patiente avec d valant 0 lorsque ladite concentration est inférieure au seuil de détection et d valant 1 lorsque ladite concentration est supérieure ou égale au seuil de détection; où e est associé au temps de prothrombine (TP) de ladite patiente avec e valant 0 lorsque ledit temps de prothrombine est supérieur ou égal à 50% et e valant 1 lorsque ledit temps de prothrombine est inférieur à 50%; où un score Z supérieur ou égal à une valeur de 2 est indicatif de la nécessité d'effectuer une procédure invasive en vue de stopper le saignement chez ladite patiente souffrant d'une hémorragie post-partum.
Patent CA-2735781-A1 (CA)
Title: Voie courte de synthese du 1,6:2,3-dianhydro-.beta.-d-mannopyranose
Inventor: BOUVENOT LAURENT
IPC: C07H19/01
Filed: 2009-09-15
Abstract: Procédé de préparation du 1,6:2,3-dianhydro-ß-D-mannopyranose, caractérisé en ce qu'il comprend une étape de cyclisation du composé B dans lequel R représente un agent activant, en présence d'une base choisie parmi les hydroxydes d'ammonium et les bases minérale.
Patent CA-2739771-A1 (CA)
Inventor: VIOVY JEAN-LOUIS
IPC: C12M3/00
Filed: 2009-10-12
Abstract: La présente invention concerne un dispositif de culture cellulaire, notamment de cellules neuronales, comportant : un support définissant une première chambre microfluidique destinée à être ensemencée, par une première culture cellulaire, et au moins une deuxième chambre microfluidique, un système d'interconnexion fluidique reliant les première et deuxième chambres et permettant à des extensions cellulaires, notamment dès axones, de s'étendre d'une chambre vers l'autre chambre, dispositif dans lequel le système d'interconnexion est réalisé de manière à privilégier la progression d'au moins un premier type d'extensions cellulaires par rapport à au moins un second type d'extensions cellulaires, lesdits premier et second types d'extensions cellulaires différant soit par la chambre microfluidique dont ils proviennent, soit par le type cellulaire dont ils sont l'extension.
Patent CA-2741089-A1 (CA)
Inventor: WATTS RYAN
IPC: A61K31/7105
Filed: 2009-10-22
Abstract: The invention relates generally to treatment of neurological disorders and nervous system injuries. The invention specifically provides methods of using modulators of particular target proteins to modulate degeneration of neurons or portions thereof, such as axons.
Patent CA-2741662-A1 (CA)
Inventor: CHARBONNEAU PATRICK
IPC: F01N11/00
Filed: 2009-11-12
Abstract: Urea supply information with is integrated with vehicle location, routing and urea consumption information to generate driver guidance for obtaining urea resupply or, at a minimum, automatically generating orders to position supplies of urea at a target location.
Patent CA-2742201-A1 (CA)
Inventor: HEYER LAURENT
IPC: A61M16/00
Filed: 2009-11-03
Abstract: The invention relates to a system characterised in that it comprises: a means (20) for acquiring information relating to the respiratory status of the patient (1) in a breathing cycle; a means (21) for acquiring information relating to the operating status of the assistance device (2) in a mechanical cycle; a means for filtering (22) and processing (23) said information to detect and locate changes in the status of the patient in a breathing cycle and of the device in a mechanical cycle; a means (24) for calculating a piece of information on the desynchronisation between the patient and the device according to said status changes; and a means (25) forming a human-machine interface for recreating said piece of desynchronisation information for an operator.
Patent CA-2743570-A1 (CA)
Inventor: AHOLA TARJA
IPC: G16B50/00
Filed: 2009-11-20
Abstract: The present invention relates to a method for determining the risk of a pregnant woman developing pre-eclampsia.  The method comprises i) determining the level of one or more biochemical markers in a sample obtained from a pregnant woman, and ii) comparing the level of the at least one biochemical marker in the sample with the level of the same biochemical marker in a control sample. A difference in the level of the biochemical marker in the sample relative to the control sample is indicative of an increased risk of developing pre-eclampsia. The isoform biochemical markers are preferably P1GF-2 and P1GF-3. The present invention relates also to a method for determining whether a pregnant woman has pre-eclampsia and as well as a kit for assessing the risk or presence of pre-eclampsia. In addition, the invention relates also to a computer program used in these determinations.
Patent CA-2744219-A1 (CA)
Inventor: PANDEY VIDHU SHEKHAR
IPC: F01D5/14
Filed: 2011-06-23
Abstract: A turbine blade includes an airfoil having a root, a tip, a concave pressure side, and a laterally opposite convex suction side, the pressure and suction sides extending in chord between opposite leading and trailing edges; an outer platform disposed at the tip of the airfoil, the outer platform having spaced-apart lateral edges which each define an interlocking element; an inner platform with two spaced-apart curved lateral edges disposed at the root of the airfoil, the inner platform having a hot side facing the airfoil which is contoured in a non-axisymmetric shape; and a dovetail extending radially inward from the opposite side of the inner platform, wherein the dovetail is axially straight.
Patent CA-2744391-A1 (CA)
Inventor: WABNITZ PHILIPP
IPC: A61P11/00
Filed: 2009-12-03
Abstract: The invention relates to cydopentabenzofuran derivatives for the treatment and/or prophylaxis of angiogenesis-related disorders.
Patent CA-2744985-A1 (CA)
Inventor: ANDO NAOKO
IPC: A61P9/10
Filed: 2009-12-01
Abstract: A compound represented by general formula (I) or a pharmaceutically acceptable salt thereof has excellent PPAR.alpha.  agonist action and lipid-lowering action, and is useful as a preventive or therapeutic agent for hyperlipidemia, etc. In general formula (I), R1 and R2 independently represent a hydrogen atom, an alkyl group, or the like; R3 represents a hydrogen atom, an alkyl group, or the like; R4 represents a hydrogen atom, an alkyl group, or the like; m represents an integer of 0 to 3; X represents a bond, an oxygen atom, or a sulfur atom; Y represents a carbonyl group, a hydroxymethylene group, or the like; and Z represents a halogen atom, an alkyl group, an aryl group, a heteroaryl group, or the like.
Patent CA-2745957-A1 (CA)
Inventor: SIGRIST CHRISTENSEN DANIEL
IPC: G06F19/00
Filed: 2009-12-17
Abstract: There is provided a system for monitoring hygiene compliance in a medical facility.  The system includes personnel tags for patients and for healthcare workers within the facility; sensors, to be carried by healthcare workers, which recognize personnel tags for patients within a distance of 1 meter; washing stations provided with tags which are recognized by said sensors within a distance of 0.5 meter; and a control unit, to be carried by the healthcare workers, said control unit being programmed to detect whether a healthcare worker bearing one of the personnel tags accessed a washing station prior to contacting a patient bearing a separate one of the personnel tags.
Patent CA-2746417-A1 (CA)
Inventor: BOBREN ALLAN J
IPC: B65B13/06
Filed: 2009-12-07
Abstract: A self-adjusting stripper pin is for use in a strap chute for a strapping machine and includes a mount mounted to a fixed portion of the strapping machine, a reciprocating pin disposed in the mount for reciprocating movement relative to the mount and a pin spring disposed between the pin and the mount for biasedly mounting the pin to the mount. When the movable wall of the strapping machine is moved toward the fixed wall of the strapping machine, the pin moves out from the track to allow the strap to traverse therethrough and when the movable wall is moved away from the fixed wall, the pin is moved into the track to urge the strap out of the track. The spring positions the pin at about an outer edge of the track when the movable wall is moved away from the fixed wall.
Patent CA-2746437-A1 (CA)
Inventor: PANDALIS GEORGIOS
IPC: A61K36/185
Filed: 2009-11-27
Abstract: The invention relates to a composition comprising an extract of the genus Ribes for use in the prophylaxis and/or treatment of viral infections. In particu-lar, the composition can be used for the prophylaxis and/or treatment of the symptoms of influenza, common cold dis-eases or viral infections caused by retroviruses.
Patent CA-2747540-A1 (CA)
Title: Solar cell module and method for producing the same
Inventor: NAKATA JOSUKE
IPC: H01L31/042
Filed: 2008-12-19
Abstract: This solar cell module (1) comprises a plurality of solar cell arrays (11).  Each solar cell array (11) includes a plurality of spherical semiconductor elements (20) arranged in a row, at least a pair of bypass diodes (40), and a pair of lead members (14) that connect the plurality of spherical semiconductor elements (20) and the plurality of bypass diodes (40) in parallel. Each of the lead members (14) includes one or plural lead strings (15) to which the plurality of spherical semiconductor elements (20) are electrically connected and having a width less than or equal to the radius of the spherical semiconductor element (20), and plural lead pieces (16) formed integrally with the lead strings (15) at least at both end portions of the lead member (14), on which the bypass diodes (40) are electrically connected in reverse parallel to the spherical semiconductor elements (20), and having width larger than or equal to the width of the bypass diodes (40).
Patent CA-2749985-A1 (CA)
Inventor: THADHANI RAVI
IPC: A61K38/17
Filed: 2009-01-23
Abstract: L'invention porte, en partie, sur l'utilisation de la gelsoline pour diagnostiquer, surveiller et traiter des sujets avec une insuffisance rénale (par exemple, des sujets atteints d'une insuffisance rénale chronique en dialyse).
Patent CA-2750043-A1 (CA)
Title: Method and system for transporting inventory items
Inventor: D ANDREA RAFFAELLO
IPC: B66F9/06
Filed: 2007-05-09
Abstract: Transporting of inventory items includes moving to a starting location associated with an inventory holder, docking with the inventory holder, and moving towards a destination location, while location of the inventory holder is determined. A difference between the determined location of the inventory holder and an anticipated location of the inventory holder is calculated and examined to determine if it is greater than a predetermined tolerance. If the difference is greater than the predetermined tolerance, then undocking from the inventory holder, determining a correction value based on the difference, wherein the correction value indicates at least one of a direction and a distance, moving based on the correction value docking with the inventory holder, and moving towards the destination location.
Patent CA-2750604-A1 (CA)
Inventor: JOHNSON LLOYD W
IPC: B01F33/40
Filed: 2009-03-23
Abstract: A downflow mixer with a gas injection device and/or a baffle plate is provided to improve performance of mixing and/or aeration in basins, lagoons or tanks, particularly as part of water or wastewater treatment.
Patent CA-2752897-A1 (CA)
Inventor: SHIPPEN SCOTT
IPC: A47F1/14
Filed: 2011-09-19
Abstract: A system, apparatus and methods for dispensing liquids is disclosed. The dispenser device and system may comprise an on-board ice and cup storage unit. The device and system may include a stand with a drip basin; a rack accommodating a cup holder and an inverted container holder/fitting for holding multiple containers, such as 2 liter bottles, with dispensing valves; and an ice bin located within the rack, which may comprise partially contoured sides around each container and around the cup holder. Dispensing valves may be lever-actuated, simulating a soda fountain delivery system. The device and system may be disassembled and nested for easy transport or storage.
Patent CA-2753858-A1 (CA)
Inventor: STEPHENS PAUL A
IPC: A01H5/10
Filed: 2010-04-15
Abstract: According to the invention, there is provided a novel soybean variety designated 93Y05. This invention thus relates to the seeds of soybean variety 93Y05, to the plants of soybean 93Y05 to plant parts of soybean variety 93Y05 and to methods for producing a soybean plant produced by crossing plants of the soybean variety 93Y05 with another soybean plant, using 93Y05 as either the male or the female parent.
Patent CA-2755671-A1 (CA)
Title: Immersed wood protection method and system
Inventor: CASTAGNA SANDRO
IPC: B27K3/26
Filed: 2010-03-17
Abstract: A method for mitigating degradation of a wooden piece immersed in water caused by the presence of microogranisms in the water and the corresponding wooden piece, in which a large number of staples made of a material comprising iron are driven into a surface of the wooden piece to be exposed to water. The staples are distributed on the surface of the wooden piece to be exposed to water with a homogeneous density of staples on the surface of the wooden piece to be exposed to water and a deepness of driving of the staples into the wooden piece. The homoegenous density of staples and the deepness of driving of the staples are adjusted to produce, by means of a chemical reaction between the water and the iron of the staples when the water immerses the exposed surface, a homogeneous ferrous oxide barrier on and underneath the water-exposed surface of a certain thickness into the wooden piece to protect the wooden piece against degradation caused by the presence of microogranisms in the water.
Patent CA-2755696-A1 (CA)
Inventor: PINKOS ROLF
IPC: C07C29/80
Filed: 2010-03-29
Abstract: The invention relates to a method for producing 1,6-hexanediol, preferably of at least 99.5% purity, which hexane-diol is especially substantially free from 1,4 cyclohexanediols, starting from a carboxylic acid mixture which is obtained as a by-product of the catalytic oxidation of cyclohexane to cyclohexanone/cyclohexanol with oxygen or gases containing oxygen and by extraction of the reaction mixture with water, and by hydrogenation of the carboxylic acid mixture, esterification and hydrogenati-on of a partial flow to hexanediol.
Patent CA-2755809-A1 (CA)
Inventor: SCHULER CARLOS A
IPC: A61K9/12
Filed: 2010-03-18
Abstract: Methods of treating atrial arrhythmia include administering an effective amount of at least one antiarrhythmic pharmaceutical agent to a patient in need thereof, such that the at least one antiarrhythmic pharmaceutical agent first enters the heart through the pulmonary vein to the left atrium. Other methods of treating atrial arrhythmia include administering by inhalation an effective amount of at least one antiarrhythmic pharmaceutical agent to a patient in need thereof. An amount of the at least one antiarrhythmic pharmaceutical agent may peak in the coronary sinus of the heart at a time ranging from 10 seconds to 30 minutes from initiation of the administering. Unit doses, aerosols, and kits are also contemplated.
Patent CA-2763935-A1 (CA)
Title: Methods for identification of sites for igg conjugation
Inventor: CHENNAMSETTY NARESH
IPC: A61K47/48
Filed: 2010-06-04
Abstract: The present disclosure relates to immunoglobulins and immunoglobulin conjugates with reduced oligomerization and efficient labeling and compositions, methods of generating such immunoglobulins and immunoglobulin conjugates and methods of using such immunoglobulin conjugates particularly in the treatment and prevention of disease.
Patent CA-2765274-A1 (CA)
Inventor: BUSCH DETLEF
IPC: H01M50/417
Filed: 2010-06-09
Abstract: Single-layer or multilayer, biaxially oriented, microporous foil having a shutdown function, which comprises at least one shutdown layer I, which comprises propylene homopolymer and .beta.-nucleating agent and polyethylene.
Patent CA-2766240-A1 (CA)
Title: Electrode base
Inventor: YOSHIDA AKIO
IPC: H01R4/02
Filed: 2009-06-23
Abstract: In the present invention, a lead wire (2) made of aluminum is bonded to a surface of a glass substrate (3) that is a thin-film base having a plate thickness of about 0.7 to 2.0 mm, by using an ultrasonic bonding method. An external lead-out electrode (23) made of copper is formed so as to extend from a surface of one end portion of the lead wire (2) to a region outside the glass substrate (3). The lead wire (2) functions as an internal signal receiver, and the external lead-out electrode (23) has an external signal transmission function.
Patent CA-2767146-A1 (CA)
Inventor: LANDMAN BERNARDUS CORNELIS JOHANNES
IPC: B29C65/58
Filed: 2010-07-02
Abstract: Preform assembly (1) for blow moulding a container (20), comprising at least a first (2) and a second (3) preform, wherein the first preform (2) is positioned inside the second preform (3) before blow moulding the preforms into the container, wherein each preform has a body forming portion having a wall thickness of less than about 8 millimetres, preferably less than about 6 mm. A container blow moulded from the preform assembly and a method and an apparatus for forming the preform assembly are also disclosed.
Patent CA-2768423-A1 (CA)
Inventor: SHAH MANDAR V
IPC: A61K8/34
Filed: 2012-02-16
Abstract: In certain embodiments, the present invention is directed to the use of soothing agents to relieve mild irritation and/or enhance the overall soothing, comfort or refreshing feel of mucosal membranes of the eye, oral cavity, otic, nose, throat or vaginal area.  The present invention further relates to compositions, articles and methods for masking or reducing the irritant properties of sensory compounds, such as terpenes and/or phenolic agents.